Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.93
1.86
NAV
₹428.69
₹37.79
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹3822.73 Cr
₹6658.41 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
1 Year
7.42%
7.38%
3 Year
25.82%
27.18%
5 Year
17.14%
16.78%
Equity
98.53%
97.60%
Cash
1.39%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018
